ScholarIQanswers from OpenAlex

Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma

PaperCitations, authors & open-access status

Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma have?

ScholarIQcitation count

Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma has 263 citations in the OpenAlex counts ScholarIQ stores.

When was Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma published?

ScholarIQyear

Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma has 2011 year in the ScholarIQ index.

What is the open-access status of Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma?

ScholarIQoa status

Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma has closed oa status in the ScholarIQ index.

What is the DOI of Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma?

ScholarIQdoi

The DOI for Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma is on the source record.

What is the PMID of Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma?

ScholarIQpmid

The PMID for Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma is on the source record.

What is the OpenAlex record for Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma?

ScholarIQopenalex

The OpenAlex for Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial